中文
Wigen biomedicine technology (Shanghai) Co., Ltd established in April 2018 is a high-tech biomedical company for developing innovative medicines. The company mainly engages in the research and development of new anti-tumor drugs and new technology platforms such as covalent / allosteric small molecules, PROTAC, and drug conjugation.
  • 2018

    Year We Established

  • 80

    Patents Applied

  • 6

    Clinical Products

More +
Building off Wigen's internal R&D platform and external technical supports, we have established a small molecule pipeline for multiple targets, and currently several products have entered into the clinical stage.
Research Fields + Pipeline +
Our team member have years of experiences in drug discovery. In Wigen, you will be working with committed, passionate and talented colleagues, and you will be provided with valuable professional experiences, and the opportunities to develop, expand and rapidly advance your career. Together, we endeavor to improve human health and bring new hopes to patients.
More +
AddressNo. 11, 67 Lane, Libing Road, Pilot Free Trade Zone, Shanghai, China
Telephone+86(21) - 53391528(Switchboard)
MailboxHR@wigenbio.com
Zip code201203

Official WeChat official account
Wigenbio

Contact Us
Copyright © 2021-2022 Wigen biomedicine technology (Shanghai) Co., Ltd. - All Rights Reserved.沪ICP备18021156号-1